Vectura concludes paediatric asthma studies
Chippenham, UK-based Vectura says it has now successfully concluded two paediatric studies to support the potential use of asthma drug/device combo VR647.
Read More
Tag: VR647
Vectura trial gets green light for smart nebuliser trial
US regulators have given UK-based Vectura a green light to carry out a Phase I clinical trial of VR647, a drug/device combination being developed for paediatric asthma.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
